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Abstract
Background: Hypertensive disorders of pregnancy (HDP) affect 5–10% of pregnant women. Women after HDP
have 2–3 times increased risk of heart attack, stroke and diabetes, as soon as 5–10 years after pregnancy. Australian
healthcare providers’ knowledge of cardiovascular disease (CVD) risks for women after HDP is unknown, and this
study aimed to explore their current knowledge and practice regarding long-term cardiovascular health after HDP,
as a precursor to producing targeted healthcare provider education on health after HDP.
Methods: A custom-created, face-validated online survey explored knowledge about long-term risks after HDP.
Distribution occurred from February to July 2019 via professional colleges, key organisations and social media. The
objective was to assess current knowledge and knowledge gaps amongst a group of healthcare providers (HCP) in
Australia, regarding long-term cardiovascular health after hypertensive disorders of pregnancy (HDP), specifically
gestational hypertension or preeclampsia.
Results: Of 492 respondents, 203 were midwives, 188 obstetricians, 75 general practitioners (GP), and 26
cardiologists. A risk knowledge score was computed with 0–6 considered low, 6.1–8.9 moderate and 9–12 high.
Most participants (85%) were aware of increased cardiovascular disease after preeclampsia and gestational
hypertension (range 76% midwives to 100% cardiologists). There were significant differences in average knowledge
scores regarding health after preeclampsia; high for cardiologists (9.3), moderate for GPs and obstetricians (8.2 and
7.6 respectively) and low for midwives (5.9). Average knowledge scores were somewhat lower for gestational
hypertension (9.0 for cardiologists, 7.4 for obstetricians and GPs, 5.1 for midwives). Knowledge was highest
regarding risk of chronic hypertension, moderate to high regarding risk of ischaemic heart disease, stroke and
recurring HDP, and low for diabetes and peripheral vascular disease. Only 34% were aware that risks start < 10 years
after the affected pregnancy.
Conclusion(s): Participants were aware there is increased cardiovascular risk after HDP, although less aware of risks
after gestational hypertension and some specific risks including diabetes. Findings will inform the development of
targeted education.
Keywords: Cardiovascular risk, Healthcare providers, Preeclampsia, Gestational hypertension, Longterm
cardiovascular health, Preventive health
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Background
Hypertensive disorders of pregnancy (HDP) includes
preeclampsia (PE), gestational hypertension (GH) and
pre-existing or chronic hypertension (CH) and compli-
cates 5–10% of pregnancies [1]. PE is a multi-system dis-
order, characterised by hypertension and involvement of
one or more other organ systems and/or the fetus [2, 3].
Gestational hypertension is new onset hypertension
without any other complications during pregnancy and
has little association with adverse pregnancy outcomes
apart from increased risk of progression to preeclampsia
[2, 3]. Both conditions are associated with long-term
cardiovascular sequelae [4, 5]. Cardiovascular disease
(CVD), the leading cause of death in women globally [6],
is up to two and a half times higher for women after
HDP versus those with no HDP [4, 5, 7, 8]. This in-
creased risk remains after adjusting for the presence of
other cardiovascular risk factors and is present within
5–10 years after the affected pregnancy [8–12].
Both Australian and international societies, including
the Society of Obstetric Medicine of Australia and New
Zealand (SOMANZ) and the International Society for
the Study of Hypertension in Pregnancy (ISSHP), recom-
mend women and healthcare providers (HCP) are pro-
vided with information about HDP and later CVD, and
HCPs should ask women about their HDP history when
assessing cardiovascular health and risk factors. This in-
cludes review at 3 months postpartum and regular
follow-up with a GP to monitor blood pressure, fasting
lipids and blood sugar [2]. Recommendations emphasise
adoption of a healthy lifestyle with maintenance of an
ideal weight and regular aerobic exercise [2, 3]. Despite
existing evidence and recommendations, it is unknown
whether Australian HCPs are aware of the association
between HDP and CVD [13]. The aim of this study was
to explore Australian HCPs current knowledge and
practice regarding long-term cardiovascular health after
HDP, as a precursor to producing targeted HCP educa-
tion on health after HDP.
Method
A national, multidisciplinary survey of HCPs was con-
ducted, using a custom-created, face-validated online
survey (Additional file 1). Ethical approval was provided
by South-Eastern Sydney Human Research Ethics Com-
mittee (Ref: 18/POWH/326).
Face validation of the survey
As a validated instrument to assess HCP’s knowledge
and practice was unavailable, a survey was custom de-
signed. The survey was initially compiled from a scoping
literature review [13] and complemented by questions
specifically exploring the Australian context. Twenty-
one HCPs across eight professions (obstetricians,
cardiologists, nephrologists, obstetric physicians, anaes-
thetists, general practitioners, midwives and community
health nurses) participated in the face-validation process.
These HCPs commented on content, language, flow,
survey structure including length, whether the risk pro-
file at survey conclusion was informative, and potential
value of the survey data. The survey was modified until
consensus over a final version was achieved.
Data collection
The online survey, powered by SurveyMonkey (Survey
Monkey Inc., San Mateo, USA), was open from 15 Feb-
ruary until 4 August 2019. Survey distribution occurred
through professional organisations, namely: The Royal
Australian and New Zealand College of Obstetricians
and Gynaecologists (RANZCOG) [targeted to DRANZ-
COG holders (General Practitioners with obstetrics and
gynaecology diploma) and FRANZCOG (Fellow) mem-
bers], the Australian College of Midwives (ACM), and
the Cardiac Society of Australia and New Zealand
(CSANZ). Additionally, distribution occurred via the
study team’s professional networks, as well as social
media pathways such as Twitter and Facebook. The tar-
geting of general practitioners/family doctors (GPs) with
an obstetric diploma, and therefore specialised in mater-
nity care and women’s health, was a deliberate decision.
With our survey identifying a ‘best-case’ knowledge sce-
nario within this group of HCPs meant that we expected
our sample to have higher overall knowledge on this
topic, relative to all Australian HCPs in the included
professions, setting an upper limit regarding future tar-
geted education.
The survey collected demographic details and assessed
HCPs general and specific knowledge of risk after HDP,
and their practices around consultation and follow up of
women with a history of HDP. Early in the survey, HCPs
were asked ‘Do you think that there is an increased risk
of developing future cardiovascular disease after
gestational hypertension or preeclampsia?’. Those who
answered ‘Neither gestational hypertension or pre-
eclampsia increase the long-term health risks’, were sent
to the risk profile at the end of the survey so that de-
tailed questions regarding risk were only being asked of
those HCPs with some knowledge of CVD and HDP
links. The HCPs were asked to classify the risk of
women with a history of GH or PE, of various long-term
health outcomes as ‘less than’, ‘equal to’ or ‘greater than’
that of a woman with a normotensive pregnancy. The
survey included conditions that women are at increased
risk of after HDP (chronic hypertension, CVD, diabetes,
renal disease) and also those with similar prevalence
(breast cancer, leukaemia and seizures). Upon survey
completion, HCPs were provided with a correct risk pro-
file summary and a link to further information.
Roth et al. BMC Pregnancy and Childbirth          (2020) 20:717 Page 2 of 9
Commencement of the survey was taken as consent to
participate.
Data analysis
Quantitative survey analysis was undertaken using SPSS
Version 25 (SPSS Statistics for Windows, Armonk, NY).
Demographic data and responses to individual questions
were analysed descriptively. To examine difference in
knowledge levels amongst the targeted HCP subgroups,
(obstetricians, GPs, midwives, cardiologists) responses
regarding HDP and future health risks were compared
using Chi-squared testing for categorical data and one-
way ANOVA for continuous data. A p-value of < 0.05
was considered statistically significant.
For ease of interpretation, a knowledge score was
created for the GH and PE risk matrix, whereby 1
point was allocated to the correct answer, 0 for the
incorrect answer, 0 for ‘I do not know’ and 0 for no
answer/left blank. A mean score for each risk factor
was calculated and a scale of ‘low’, ‘moderate’ and
‘high’ knowledge was established. The ranking classifi-
cations were chosen based on the data distribution.
For individual risk mean scores, ‘low knowledge’
equated to a mean of 0.00–0.50, ‘moderate knowledge’
was 0.51–0.80 and ‘high knowledge’ a mean of 0.81–
1.00. An overall mean score out of 12 (as there were
12 conditions) was given for GH and PE for each
profession. A ‘low knowledge’ equated to a mean of
0–6 (50% or less correct answers), a mean of 6.1–8.9
was considered ‘moderate knowledge’, and a mean
score of 9–12 was considered ‘high knowledge’.
Results
In total, 573 survey responses were received (Fig. 1).
Eighty-one were excluded: 48 for not answering the key
inclusion question ‘Do you think that there is an in-
creased risk of developing future cardiovascular disease
after gestational hypertension or preeclampsia?’ and 33
for representing diverse professions that were not the
target HCPs. Of 492 included responses 203 (41%) were
from midwives, 75 (15%) GPs, 188 (38%) obstetrician/
gynaecologists and 26 (5%) cardiologists. Of these, 446
provided responses to the detailed knowledge questions.
Most respondents were female (82%) and approximately
half had > 15 years’ experience in their profession, with
the exception of cardiologists (70% 10 years or less in
the profession). Almost all respondents (94%) see/treat
women with a history of PE or GH, and the majority
(78%) stated they routinely ask women about their preg-
nancy history including GH or PE (Table 1). Most re-
spondents were aware of the increased CVD risk after
both PE and GH (85%), while 6% thought only PE (4%)
or GH (2%) increased risk, but not both (Table 2). The
9.3% who did not know (8.5%) or believed that neither
GH nor PE (0.8%) carried a risk were directed to the end
of the survey, with the remaining 446 respondents di-
rected towards more in-depth knowledge questions.
Overall, most professions had ‘high’ knowledge with
regards to women developing chronic hypertension after
PE and GH (Table 3). Although ‘high’ knowledge was
displayed for HDP recurrence after PE (‘moderate’ for
midwives at 0.72, GP 0.84, obstetricians 0.90, cardiolo-
gists 0.96), more varied results were noted for recurrence
of HDP after GH, ranging from ‘low’ for midwives,
‘moderate’ for GPs and obstetricians to ‘high’ for cardiol-
ogists. Lowest knowledge across all four professions
regarded future diabetes risk for both PE (range mid-
wives 0.30 to cardiologists 0.81) and GH (from midwives
0.25 to cardiologists 0.65). Another low scoring condi-
tion was peripheral vascular disease (PVD), where know-
ledge was ‘low’ to ‘moderate’ for both PE and GH.
Additional file 2 shows the detailed breakdown of re-
spondent answers, including proportion answering ‘I
don’t know’ or skipping questions versus giving a firm
but incorrect answer. Conditions with the highest pro-
portion of “I don’t know” answers were diabetes, PVD,
and the three distractors (breast cancer, leukaemia and
seizures).
Overall average knowledge scores were ‘low’ for mid-
wives (5.9 for PE and 5.1 for GH), ‘moderate’ for GPs
(7.6 PE, 7.4 GH) and obstetricians (8.2 PE, 7.5 GH) and
‘high’ for cardiologists (9.3 PE and 9.0 GH). Only 34%
were aware that the risks start to manifest less than 10
years after an affected pregnancy (Table 4). Regarding
usual practice around risk discussion with women after
HDP, the most frequent practices by all professions were
assessing CVD risk (61%) and recommending lifestyle
changes (66%) (Table 5).
Discussion
In this novel Australian HCP survey, most respon-
dents (85%) were aware that both GH and PE in-
crease the long-term risk of CVD and ‘always’ (78%)
ask about HDP history. Despite this reasonably high
awareness of HDP being linked to future CVD risks,
we identified significant knowledge gaps regarding in-
dividual conditions. All professions had consistently
lower knowledge scores regarding conditions after
GH. This may be because GH is seen as a more be-
nign form of HDP, although studies show GH has
similar CVD risk to preeclampsia [4, 14].
Within the context of the selected sample of HCPs,
findings were expected to reflect a ‘best-case’ scenario of
knowledge as their specialised training theoretically indi-
cates high overall knowledge. Of the total respondent
number (n = 573), 48 (8%) were excluded for not an-
swering the key risk question asked (‘Do you think that
there is an increased risk of developing future
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cardiovascular disease after gestational hypertension or
preeclampsia?’) and 46 of the n = 492 respondents (9%)
for being unsure or not believing there are health risks
after HDP. Therefore, even in this sample, with sufficient
interest in the topic to undertake the survey, a minority
had very low or incorrect overall knowledge. Education
developed will need to cater to HCPs with no pre-
existing knowledge as well as focus on the specific gaps
identified by the survey.
International studies exploring HCPs knowledge
have reported overall low knowledge [13]. These stud-
ies feature results from highly specialised HCPs with
substantial involvement in maternity and women’s
health care. Only one study has examined knowledge
of HCPs on long-term health risks after both PE and
GH, whilst all others focus on risks after PE only
[15]. In line with another study that found that higher
knowledge was associated with belonging to a particu-
lar profession [16], we found higher knowledge
among medical professionals compared with mid-
wives. However, in contrast to an American study
that found obstetricians generally had more awareness
of CVD after PE than internal medicine physicians
[17], cardiologists were the highest scoring profession
in this survey, DRANZCOG GPs and obstetricians
were quite similar.
This study identified some significant knowledge gaps
amongst specialist HCPs. Our study findings resonate
with those from similarly targeted HCPs in Canada,
Germany, Nigeria and the USA conducted between 2007
and 2017 [13]. Therefore, from a global perspective, this
reinforces the research to practice gap in yet another
country a few years on. With international guidelines,
including ISSHP 2018 [2], specifically targeted to assist
HCPs on an international scale to better manage and
address health after HDP, this practice gap would be ex-
pected to narrow.
Given the different scope of practice of various pro-
fessions, different knowledge and knowledge gaps
were expected, and our results can help tailor future
education of different HCPs on this topic. For ex-
ample, options might include improving knowledge
about the risks associated with GH amongst specialist
GPs and obstetricians. Once this educational material
has been piloted with the specialised HCPs, it may be
adapted to suit a broader distribution which would
include, for example, GPs without specialist qualifica-
tion in women’s health.
Fig. 1 Survey inclusion. Flowchart of respondents included and excluded in the survey analysis
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Total N 203 75 188 26 492
SEX
Female 200 (98) 63 (84) 119 (63) 22 (85) 404 (82)
Male 2 (1) 12 (16) 66 (35) 4 (15) 84 (17)
Prefer not to answer 1 (1) 0 (0) 3 (2) 0 (0) 4 (1)
YEARS OF EXPERIENCE
< 5 years 38 (19) 12 (16) 23 (12) 10 (39) 83 (17)
5–10 years 28 (14) 17 (23) 47 (25) 8 (31) 100 (24)
11–15 years 29 (14) 9 (12) 26 (14) 3 (12) 67 (14)
> 15 years 107 (53) 36 (48) 92 (49) 5 (19) 240 (49)
Prefer not to answer 1 (0.5) 1 (1) 0 (0) 0 (0) 1 (0)
STATE OF PRACTICE
New South Wales 103 (51) 17 (23) 55 (29) 8 (31) 183 (37)
Victoria 29 (14) 23 (31) 39 (21) 17 (65) 108 (22)
Australian Capital Territory 7 (4) 0 (0) 8 (4) 0 (0) 15 (3)
Queensland 26 (13) 13 (17) 35 (19) 0 (0) 74 (15)
Northern Territory 5 (3) 2 (3) 4 (2) 0 (0) 11 (2)
South Australia 17 (8) 5 (7) 16 (9) 1 (4) 39 (8)
Tasmania 5 (3) 0 (0) 11 (6) 0 (0) 16 (3)
Western Australia 9 (5) 15 (20) 20 (11) 0 (0) 44 (9)
SEE/TREAT WOMEN WITH HISTORY OF PE OR GH
Yes 139 (95) 73 (97) 177 (94) 18 (69) 461 (94)
No 10 (5) 2 (3) 11 (6) 8 (31) 31 (6)
ROUTINELY ASK ABOUT PREGNANCY HISTORY INCLUDING GH OR PE
Always 174 (86) 40 (53) 161 (86) 8 (31) 383 (78)
Often 18 (9) 21 (28) 16 (8) 8 (31) 63 (13)
Sometimes 8 (4) 14 (19) 11 (6) 9 (35) 42 (9)
Never 3 (2) 0 (0) 0 (0) 1 (4) 4 (1)
PE preeclampsia, GH gestational hypertension
a percentages may not add to 100% as figures are rounded to whole numbers only











n = yes (%) n = yes (%) n = yes (%) n = yes (%) n = yes (%)
PE only 12 (6) 1 (1) 7 (4) 0 (0) 20 (4)
GH only 4 (2) 3 (4) 2 (1) 0 (0) 9 (2)
PE and GH 155 (76) 67 (89) 169 (90) 26 (100) 417 (85)
Neither 1 (1) 0 (0) 3 (2) 0 (0) 4 (1)
I am not sure 31 (15) 4 (5) 7 (4) 0 (0) 42 (9)
Proceed to rest of survey 171 (84) 71 (95) 178 (95) 26 (100) 446 (91)
Discontinued from data collection 32 (16) 4 (5) 10 (5) 0 (0) 46 (9)
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In this study, the condition following PE or GH associ-
ated with the highest knowledge was chronic hyperten-
sion, consistent with previous HCP studies [15–18].
Knowledge was lowest with regards to PVD and diabetes
across all groups. The wide range of knowledge levels
displayed within this study concerning risk of recurring
HDP was an unexpected finding and suggests further
need for maternity care provider education on this topic.
Only one-third of respondents were aware that risks
start to manifest under 10 years after an HDP pregnancy,
which may negatively impact on timely follow up and
counselling of affected women. In combination with pre-
dominantly low to moderate knowledge of most individ-
ual CVD conditions explored within this study, this
suggests opportunities are currently being lost to discuss
preventive strategies that could improve women’s health
trajectories. The majority of participants were female.
Given that midwifery is a predominantly female occupa-
tion in Australia, and GPs and obstetricians closer to 50:
50, the response rate of male versus female within these
three professions is not unexpected. However, given that
a minority of Australian cardiologists are female, the
high fraction of cardiology respondents being women
suggests bias in this sample.
As with all surveys, it is uncertain how representative
it is of the population under study i.e. it is unknown
whether knowledge of non-respondents is comparable to
that of respondents. Furthermore, the number of re-
spondents in all included subgroups are a small propor-
tion of the national registers (particularly cardiologists)
which suggests volunteer bias and also affects generalis-
ability. However, non-representative national HCP num-
bers along with a highly specialised sample of HCPs can
be noted within all research addressing HCP knowledge
[13]. This study was also subject to sample limitations as
specialised maternity and women’s health HCPs with
prior knowledge of the link between HDP and CVD
were included in the analysis e.g. the targeting of GP dis-
tribution to DRANZCOG holders. This was, however, a
deliberate decision, since it can reasonably be expected










































































































































































0.33 (low) 0.49 (low) 0.44 (low) 0.46 (low) 0.27 (low) 0.35 (low) ≤0.001 ≤0.001



















CH chronic hypertension, IHD ischaemic heart disease, MI myocardial infarction, HDP hypertensive disorder of pregnancy, PVD peripheral vascular disease,
mod moderate
a Breast cancer, leukaemia and seizures are distractors within the survey. These were included despite being conditions that women after HDP are not at greater
risk of
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that these specialised GPs have highest, relative know-
ledge. Therefore, the knowledge gaps that were found
can be expected to extend to the wider Australian GP
population. In addition, we targeted these specialised
GPs with awareness that response rates to GP surveys
are generally very low. For example, recruited numbers
were < 15% in this study despite various, targeted re-
cruitment strategies in place [19]. A more general/inclu-
sive spread of midwives, GPs, obstetricians would likely
have lesser knowledge than our sample as fewer mater-
nal health qualifications (GPs) and/or not be interested
enough in the topic to take the survey. Therefore, when
designing education it would be wise to cater for no
higher than the levels of knowledge exhibited in our
sample, and also cater for lower levels of knowledge.
Our custom-created knowledge score is both a
strength, as it allows for a summary of findings across
all the conditions and risks, and a limitation, as
assigning cut-points is an arbitrary designation. Hav-
ing included the distractor conditions (breast cancer,
leukaemia and seizures) may also have altered the
overall score. However, we believe it is important that
knowledge is both of conditions that actually do
occur more often after GH/PE, plus not incorrectly
believing these women are at increased risk of more
conditions than they are.
What are the implications?
Research on increased CVD risk after HDP emerged in
the early 2000s with the first systematic review published
in 2007 [20]. Since then, further research has supported
these findings [7], providing close to two decades worth
of data signalling the link between HDP and increased
CVD risk. Given the length of time that this topic has
been addressed in research, it can be an expectation that
this knowledge would by now have been translated into
practice, particularly amongst our sample that was most
likely to include ‘best-case knowledge’ HCPs. That our
results did not find this suggests both an even greater
knowledge gap in those unaware of the link as well as
amongst the non-specialised groups, and ongoing failure
to close the knowledge to practice gap on health after
HDP. Therefore, this study is valuable from the public
health perspective, given the wider context of prevalence
and importance of cardiovascular disease in women.
ISSHP [2] and SOMANZ [3] recommendations sug-
gest regular follow-up after HDP as well as counselling
about women’s individual long-term CVD risk. Design-
ing suitable education for HCPs, appropriate for general
use in the Australian healthcare setting and trialling
their implementation, would be an important step to-
wards closing the knowledge gap. It is important to es-
tablish preferred content and presentation of education











n (%)a n (%)a n (%)a n (%)a n (%)a
< 10 years after pregnancy 44 (28) 25 (38) 67 (39) 14 (54) 150 (34)
11–15 years after pregnancy 46 (29) 29 (44) 71 (42) 10 (39) 156 (32)
16–20 years after pregnancy 17 (11) 5 (8) 9 (5) 1 (4) 32 (7)
> 20 years after pregnancy 11 (7) 1 (2) 6 (4) 0 (0) 12 (3)
Not sure/I don’t know 42 (26) 6 (9) 17 (10) 1 (4) 49 (11)
Did not answer 11 (6) 5 (7) 8 (4) 0 (0) 24 (5)
Total answers 160 (93) 66 (93) 170 (96) 26 (100) 422 (95)
a Percentages may not add to 100% as figures are rounded to whole numbers only











n (%)b n (%)b n (%)b n (%)b n (%)b
Assess CV risk 69 (40) 59 (83) 120 (67) 23 (88) 271 (61)
Medication 21 (12) 16 (23) 28 (16) 10 (38) 75 (17)
Lifestyle adjustments 84 (49) 56 (79) 134 (75) 20 (77) 294 (66)
Not discussed risk 68 (40) 4 (6) 15 (8) 2 (8) 89 (20)
Othera 4 (2) 0 (0) 3 (2) 0 (0) 7 (2)
a Other includes (n = 7): Further specialist follow up (n = 3), referral letter to GP informing of risks and organise long-term care post HDP (n = 1), mental health
assessment/solutions (n = 2), advise women to disclose HDP as part of their medical history (n = 1)
bPercentages may not always add up to 100% as HCPs were asked to select any/all that apply
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for post-HDP health for clinicians, as well as gain insight
on enablers and barriers to referral, access and uptake of
follow up consultations.
Conclusion
In our Australian survey of HCP knowledge of risks after
HDP, we have found varying knowledge from the tar-
geted professions. Despite ‘high’ knowledge being dem-
onstrated in some areas, significant knowledge gaps
were identified. These gaps with regards to general and
specific disease risks for women post HDP are important
in planning tailored education for HCPs. This may in
turn assist in early identification of CVD risk factors in
women with a history of HDP and improved subsequent
counselling and management.
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